{"id":"https://openalex.org/W4388760673","doi":"https://doi.org/10.3390/vaccines11111725","title":"Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial","display_name":"Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial","publication_year":2023,"publication_date":"2023-11-17","ids":{"openalex":"https://openalex.org/W4388760673","doi":"https://doi.org/10.3390/vaccines11111725","pmid":"https://pubmed.ncbi.nlm.nih.gov/38006057","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10675090"},"language":"en","primary_location":{"id":"doi:10.3390/vaccines11111725","doi":"https://doi.org/10.3390/vaccines11111725","is_oa":true,"landing_page_url":"https://doi.org/10.3390/vaccines11111725","pdf_url":"https://www.mdpi.com/2076-393X/11/11/1725/pdf?version=1700203034","source":{"id":"https://openalex.org/S4210226234","display_name":"Vaccines","issn_l":"2076-393X","issn":["2076-393X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2076-393X/11/11/1725/pdf?version=1700203034","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044905669","display_name":"Ben Baker","orcid":"https://orcid.org/0000-0003-1561-3013","observed_orcids":["https://orcid.org/0000-0003-1561-3013"]},"institutions":[{"id":"https://openalex.org/I4210153216","display_name":"Vaxxas (Australia)","ror":"https://ror.org/05x3zk779","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153216"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"S. Ben Baker","raw_affiliation_strings":["Vaxxas Pty Ltd., Hamilton, QLD 4007, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxxas Pty Ltd., Hamilton, QLD 4007, Australia","institution_ids":["https://openalex.org/I4210153216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053592239","display_name":"Imogen M. Bermingham","orcid":"https://orcid.org/0000-0003-4746-5625","observed_orcids":["https://orcid.org/0000-0003-4746-5625"]},"institutions":[{"id":"https://openalex.org/I4210153216","display_name":"Vaxxas (Australia)","ror":"https://ror.org/05x3zk779","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153216"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Imogen Bermingham","raw_affiliation_strings":["Vaxxas Pty Ltd., Hamilton, QLD 4007, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxxas Pty Ltd., Hamilton, QLD 4007, Australia","institution_ids":["https://openalex.org/I4210153216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003783041","display_name":"Indika Leelasena","orcid":"https://orcid.org/0009-0004-7786-623X","observed_orcids":["https://orcid.org/0009-0004-7786-623X"]},"institutions":[{"id":"https://openalex.org/I174025329","display_name":"University of the Sunshine Coast","ror":"https://ror.org/016gb9e15","country_code":"AU","type":"education","lineage":["https://openalex.org/I174025329"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Indika Leelasena","raw_affiliation_strings":["University of the Sunshine Coast Clinical Trials Centre, Sippy Downs, QLD 4556, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of the Sunshine Coast Clinical Trials Centre, Sippy Downs, QLD 4556, Australia","institution_ids":["https://openalex.org/I174025329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022414876","display_name":"Julian Hickling","orcid":"https://orcid.org/0000-0001-6178-1953","observed_orcids":["https://orcid.org/0000-0001-6178-1953"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julian Hickling","raw_affiliation_strings":["Working in Tandem Ltd ; Cambridge CB1 7AB , United Kingdom","Working in Tandem Ltd., Cambridge CB1 7AB, UK"],"raw_orcid":"https://orcid.org/0000-0001-6178-1953","affiliations":[{"raw_affiliation_string":"Working in Tandem Ltd ; Cambridge CB1 7AB , United Kingdom","institution_ids":[]},{"raw_affiliation_string":"Working in Tandem Ltd., Cambridge CB1 7AB, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072766818","display_name":"Paul R. Young","orcid":"https://orcid.org/0000-0002-2040-5190","observed_orcids":["https://orcid.org/0000-0002-2040-5190"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Paul R. Young","raw_affiliation_strings":["School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD 4072, Australia"],"raw_orcid":"https://orcid.org/0000-0002-2040-5190","affiliations":[{"raw_affiliation_string":"School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD 4072, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032624215","display_name":"David Alexander Muller","orcid":"https://orcid.org/0000-0003-4375-7890","observed_orcids":["https://orcid.org/0000-0003-4375-7890"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David A. Muller","raw_affiliation_strings":["School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD 4072, Australia"],"raw_orcid":"https://orcid.org/0000-0003-4375-7890","affiliations":[{"raw_affiliation_string":"School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD 4072, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015270214","display_name":"Angus Harry Forster","orcid":"https://orcid.org/0000-0002-5363-2015","observed_orcids":["https://orcid.org/0000-0002-5363-2015"]},"institutions":[{"id":"https://openalex.org/I4210153216","display_name":"Vaxxas (Australia)","ror":"https://ror.org/05x3zk779","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153216"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Angus H. Forster","raw_affiliation_strings":["Vaxxas Pty Ltd., Hamilton, QLD 4007, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxxas Pty Ltd., Hamilton, QLD 4007, Australia","institution_ids":["https://openalex.org/I4210153216"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5015270214"],"corresponding_institution_ids":["https://openalex.org/I4210153216"],"apc_list":{"value":2200,"currency":"CHF","value_usd":2447},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2447},"fwci":2.5833,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.9,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"11","issue":"11","first_page":"1725","last_page":"1725"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14126","display_name":"Intramuscular injections and effects","score":0.08349999785423279,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":0.02539999969303608,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/measles-rubella-vaccine","display_name":"measles-rubella vaccine","score":0.859000027179718},{"id":"https://openalex.org/keywords/microarray-patches","display_name":"microarray patches","score":0.8270000219345093},{"id":"https://openalex.org/keywords/transdermal-vaccine-delivery","display_name":"transdermal vaccine delivery","score":0.6679999828338623},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.4429999887943268},{"id":"https://openalex.org/keywords/vaccine-immunogenicity","display_name":"vaccine immunogenicity","score":0.7749999761581421},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8880000114440918},{"id":"https://openalex.org/keywords/seroconversion","display_name":"seroconversion","score":0.8519999980926514},{"id":"https://openalex.org/keywords/vaccine-stability","display_name":"vaccine stability","score":0.4560000002384186},{"id":"https://openalex.org/keywords/temperature-excursions","display_name":"temperature excursions","score":0.5339999794960022},{"id":"https://openalex.org/keywords/measles-antibodies","display_name":"measles antibodies","score":0.43299999833106995},{"id":"https://openalex.org/keywords/rubella-antibodies","display_name":"rubella antibodies","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5009999871253967},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.3050000071525574},{"id":"https://openalex.org/keywords/healthy-adults","display_name":"healthy adults","score":0.5170000195503235},{"id":"https://openalex.org/keywords/vaccine-storage-and-transport","display_name":"vaccine storage and transport","score":0.35499998927116394},{"id":"https://openalex.org/keywords/needle-free-vaccination","display_name":"needle-free vaccination","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8398467302322388},{"id":"https://openalex.org/C2778814567","wikidata":"https://www.wikidata.org/wiki/Q155857","display_name":"Rubella","level":4,"score":0.7174417972564697},{"id":"https://openalex.org/C2776438120","wikidata":"https://www.wikidata.org/wiki/Q79793","display_name":"Measles","level":3,"score":0.6670432090759277},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5980240702629089},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5946822762489319},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5849863290786743},{"id":"https://openalex.org/C2780657872","wikidata":"https://www.wikidata.org/wiki/Q6804161","display_name":"Measles vaccine","level":4,"score":0.5218607187271118},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5117590427398682},{"id":"https://openalex.org/C2777451964","wikidata":"https://www.wikidata.org/wiki/Q2141450","display_name":"Seroconversion","level":3,"score":0.49100688099861145},{"id":"https://openalex.org/C2778199166","wikidata":"https://www.wikidata.org/wiki/Q573943","display_name":"Measles virus","level":4,"score":0.4741211235523224},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4182376265525818},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3779143691062927},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31188392639160156},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2145017385482788},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1305568814277649},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3390/vaccines11111725","doi":"https://doi.org/10.3390/vaccines11111725","is_oa":true,"landing_page_url":"https://doi.org/10.3390/vaccines11111725","pdf_url":"https://www.mdpi.com/2076-393X/11/11/1725/pdf?version=1700203034","source":{"id":"https://openalex.org/S4210226234","display_name":"Vaccines","issn_l":"2076-393X","issn":["2076-393X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"journal-article"},{"id":"doi:10.20944/preprints202308.0501.v1","doi":"https://doi.org/10.20944/preprints202308.0501.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202308.0501.v1","pdf_url":"https://www.preprints.org/manuscript/202308.0501/v1/download","source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:10675090","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10675090","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10675090/pdf/vaccines-11-01725.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines (Basel)","raw_type":"Text"},{"id":"pmid:38006057","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38006057","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:d005e91aac3a475aba6fb0f315429c08","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d005e91aac3a475aba6fb0f315429c08","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vaccines, Vol 11, Iss 11, p 1725 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/vaccines11111725","doi":"https://doi.org/10.3390/vaccines11111725","is_oa":true,"landing_page_url":"https://doi.org/10.3390/vaccines11111725","pdf_url":"https://www.mdpi.com/2076-393X/11/11/1725/pdf?version=1700203034","source":{"id":"https://openalex.org/S4210226234","display_name":"Vaccines","issn_l":"2076-393X","issn":["2076-393X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G756679059","display_name":"Vaxxas Pty Ltd - to develop a microneedle array patch for measles and rubella vaccination that enables house-to-house campaigns via administration by minimally-trai...","funder_award_id":"INV-003551","funder_id":"https://openalex.org/F4320306137","funder_display_name":"Bill and Melinda Gates Foundation"}],"funders":[{"id":"https://openalex.org/F4320306137","display_name":"Bill and Melinda Gates Foundation","ror":"https://ror.org/0456r8d26"},{"id":"https://openalex.org/F4320310131","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57"},{"id":"https://openalex.org/F4320310184","display_name":"Australian National Fabrication Facility","ror":"https://ror.org/04ypnrn45"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388760673.pdf","grobid_xml":"https://content.openalex.org/works/W4388760673.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W2004945323","https://openalex.org/W2040125070","https://openalex.org/W2088368520","https://openalex.org/W2091377832","https://openalex.org/W2118257082","https://openalex.org/W2525326926","https://openalex.org/W2732601320","https://openalex.org/W2782357849","https://openalex.org/W2787573902","https://openalex.org/W2801476146","https://openalex.org/W2804983248","https://openalex.org/W2921911035","https://openalex.org/W2922122230","https://openalex.org/W2924770817","https://openalex.org/W2984679203","https://openalex.org/W2996669727","https://openalex.org/W3040309501","https://openalex.org/W3128320185","https://openalex.org/W3157570473","https://openalex.org/W3177332222","https://openalex.org/W3184312365","https://openalex.org/W3187000842","https://openalex.org/W3193817695","https://openalex.org/W3204309574","https://openalex.org/W4200055909","https://openalex.org/W4200204393","https://openalex.org/W4214890236"],"related_works":["https://openalex.org/W2996669727","https://openalex.org/W4387581179","https://openalex.org/W2801476146","https://openalex.org/W3184312365","https://openalex.org/W4402749408","https://openalex.org/W3023579762","https://openalex.org/W7221425200","https://openalex.org/W4295693607","https://openalex.org/W3042845459","https://openalex.org/W4402643061"],"abstract_inverted_index":{"Microarray":[0],"patches":[1],"(MAPs)":[2],"have":[3],"the":[4,18,42,216,256],"potential":[5],"to":[6,47,66,140,191,253,262,282],"be":[7,275],"a":[8,33,49,94,147,276],"safer,":[9],"more":[10,14],"acceptable,":[11],"easier-to-use,":[12],"and":[13,26,113,156,171,188,193,199,203,221,227,232,235,246,285],"cost-effective":[15],"means":[16,278],"for":[17,123,135,143,215,230,238,244,279],"administration":[19],"of":[20,98,152,186,258],"vaccines":[21,110,263],"than":[22],"injection":[23,97],"by":[24,197,265],"needle":[25],"syringe.":[27],"Here,":[28],"we":[29],"report":[30],"findings":[31],"from":[32],"randomized,":[34],"partially":[35],"double-blinded,":[36],"placebo-controlled":[37],"Phase":[38],"I":[39],"trial":[40,290],"using":[41],"Vaxxas":[43],"high-density":[44],"MAP":[45],"(HD-MAP)":[46],"deliver":[48],"measles":[50,192,245],"rubella":[51,194,247],"(MR)":[52],"vaccine.":[53],"Healthy":[54],"adults":[55],"(N":[56],"=":[57],"63,":[58],"age":[59],"18\u201350":[60],"years)":[61],"were":[62,111,138,180,195,224,242],"randomly":[63],"assigned":[64],"1:1:1:1":[65],"four":[67],"groups:":[68],"uncoated":[69],"(placebo)":[70],"HD-MAPs,":[71],"low-dose":[72,198,217],"MR":[73,101,109,129,157,166,201],"HD-MAPs":[74,117,130,158,202,273],"(~3100":[75],"median":[76],"cell-culture":[77],"infectious":[78],"dose":[79],"[CCID50]":[80],"measles,":[81,89,231],"~4300":[82],"CCID50":[83,88,91,105],"rubella);":[84,92],"high-dose":[85,200,219],"MR-HD-MAPs":[86],"(~9300":[87],"~12,900":[90],"or":[93,175,182],"sub-cutaneous":[95],"(SC)":[96],"an":[99],"approved":[100],"vaccine,":[102],"MR-Vac":[103,222],"(\u22651000":[104],"per":[106],"virus).":[107],"The":[108,205,268],"stable":[112],"remained":[114],"viable":[115],"on":[116,210],"when":[118],"stored":[119,131],"at":[120,124,132,249],"2\u20138":[121,133],"\u00b0C":[122,134,142],"least":[125],"24":[126,136],"months.":[127],"When":[128],"months":[137],"transferred":[139],"40":[141],"3":[144],"days":[145],"in":[146],"controlled":[148],"temperature":[149],"excursion,":[150],"loss":[151],"potency":[153],"was":[154,169],"minimal,":[155],"still":[159],"met":[160],"World":[161],"Health":[162],"Organisation":[163],"(WHO)":[164],"specifications.":[165],"HD-MAP":[167,220],"vaccination":[168,214],"safe":[170],"well-tolerated;":[172],"any":[173],"systemic":[174],"local":[176],"adverse":[177],"events":[178],"(AEs)":[179],"mild":[181],"moderate.":[183],"Similar":[184],"levels":[185],"binding":[187],"neutralizing":[189,206],"antibodies":[190,248],"induced":[196],"MR-Vac.":[204],"antibody":[207],"seroconversion":[208],"rates":[209],"day":[211],"28":[212],"after":[213],"HD-MAP,":[218],"groups":[223],"37.5%,":[225,233],"18.8%":[226],"35.7%,":[228,236],"respectively,":[229,237],"25.0%":[234],"rubella.":[239],"Most":[240],"participants":[241,259],"seropositive":[243],"baseline,":[250],"which":[251],"appeared":[252],"negatively":[254],"impact":[255],"number":[257],"that":[260],"seroconverted":[261],"delivered":[264],"either":[266],"route.":[267],"data":[269],"reported":[270],"here":[271],"suggest":[272],"could":[274],"valuable":[277],"delivering":[280],"MR-vaccine":[281],"hard-to-reach":[283],"populations":[284],"support":[286],"further":[287],"development.":[288],"Clinical":[289],"registry":[291],"number:":[292],"ACTRN12621000820808.":[293]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":8}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-11-18T00:00:00"}